Skip to main content
. 2024 Sep 3;16(17):3066. doi: 10.3390/cancers16173066

Figure 1.

Figure 1

Distributions of pathogenic or likely pathogenic mutations identified in different cohorts. (a) High-risk cohort (HR, n = 3935) comprised high-risk breast cancer patients fulfilling the NCCN genetic testing criteria. (b) Unselected breast cancer cohort (n = 90) who fulfilled the NCCN genetic testing criteria. (c) Unselected breast cancer cohort (n = 217) who did not fulfill the NCCN genetic testing criteria. (d) Benign breast lesion cohort (NC, n = 99) comprised of patients with benign breast diseases. Red line: high penetrance genes; blue line: moderate to low penetrance genes.